Text Size

A multicenter randomized controlled study of antioxidant supplementation with lutein for chronic central serous chorioretinopathy

Shinojima A., Sawa M., Sekiryu T., Oshima Y., Mori R., Hara C., Sugano Y., Kato A., Asato H., Yuzawa M., Gomi F., Ogura Y., Ishibashi T., Nanri T., Yasukawa T.


  • 2017
  • Ophthalmologica
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Clinical development

  • Affiliations

    Division of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine, Tokyo, Japan; Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan; Santen Pharmaceutical Co., Ltd., Osaka, Japan

Related Publications

Functional significance of commonly regulated genes in mechanically and chemically induced retinal ganglion cell death in rat eyes

Kageyama M, Ohashi K, Ota T.


Valosin-containing protein modulator KUS121 protects retinal neurons in a rat model of anterior ischemic optic neuropathy

Kikkawa C., Ikeda H.O., Hata M., Iwai S., Tsujikawa A.


Rapid and efficient generation of mature retinal organoids derived from human pluripotent stem cells via optimized pharmacological modulation of Sonic hedgehog, activin A, and retinoic acid signal transduction

Matsushita T.; Onishi A.; Matsuyama T.; Masuda T.; Ogino Y.; Kageyama M.; Takahashi M.; Uchiumi F.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022